Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DX25F6XRS
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $32,500
Award facts
- Contract value 100% obligated
- $32,499.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $32,499.90 for Stelara 90 mg/mL syringes under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain. The award, issued on August 29, 2025, with an ultimate completion date of September 22, 2025, represents a specific product delivery against the company's larger Indefinite Delivery Contract (IDC) with DLA valued at $499,999,999 and valid through November 2026. No set-aside designation was applied to this delivery order, allowing DMS Pharmaceutical Group to compete on its merits as a woman-owned small business in the federal procurement marketplace.
This delivery order supports the Department of Defense's pharmaceutical supply chain requirements by providing Stelara, a biologic medication, to military health facilities. Stelara is an immunosuppressant used to treat various autoimmune conditions, and its procurement through DMS Pharmaceutical Group ensures consistent availability of critical medications for military personnel and beneficiaries. The company's strategic positioning as a comprehensive pharmaceutical distributor to federal healthcare systems, combined with its established IDC vehicle with DLA, enables efficient fulfillment of urgent medical supply needs across the Defense Department's healthcare infrastructure.
Quick answers
Who was awarded contract SPE2DX25F6XRS?
SPE2DX25F6XRS was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 29, 2025.
How much is contract SPE2DX25F6XRS worth?
The government has obligated $32,500 on SPE2DX25F6XRS.
Is contract SPE2DX25F6XRS an order under another contract?
Yes. SPE2DX25F6XRS is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XRS competed?
The extent of competition for SPE2DX25F6XRS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award